Watch the 22 sessions from SOSV Climate Tech Summit!

Melanie Matheu

Dr. Matheu co-founded Prellis Biologics in October 2016 to address the unsolved biomedical challenge of rapid 3D printing of large, vascularized tissues. She is a specialist in two-photon imaging of the immune system, and developed Prellis’ platform technology, a combination of her multi-disciplinary experience in two-photon laser microscopy, cell biology, physiology, and biophysics. While ascribing to a form-begets-function mandate, Dr. Matheu and her team are reverse-engineering native tissue development. Through this process, she believes that it is possible to jump-start large-format vascularized tissue printing for pharmaceutical testing, rapid development of high affinity human antibodies, and production of organs for transplant applications.

Did you know?